Daleel:simplifying cloud instance selection using machine learning

Decision making in cloud environments is quite challenging due to the diversity in service offerings and pricing models, especially considering that the cloud market is an incredibly fast moving one. In addition, there are no hard and fast rules; each customer has a specific set of constraints (e.g. budget) and application requirements (e.g. minimum computational resources). Machine learning can help address some of the complicated decisions by carrying out customer-specific analytics to determine the most suitable instance type(s) and the most opportune time for starting or migrating instances. We employ machine learning techniques to develop an adaptive deployment policy, providing an optimal match between the customer demands and the available cloud service offerings. We provide an experimental study based on extensive set of job executions over a major public cloud infrastructure

Does ERP Provide a Cross-Functional View of the Firm? Challenging Conventional Wisdom for SMEs and Large French Firms

This paper defines cross-functionality as the awareness that organizational actors have of the coupled and integrated nature of processes across various business units, which allows employees to deliver products and services to customers. That the implementation of enterprise systems (ES) provides a more complete cross- functional view of the firm has been taken for granted by managers and researchers alike. The cross-functional potential of enterprise resource planning (ERP) is a widely-held assumption and is one approaching conven- tional wisdom: “Because ERPs tear down walls within organizations, they help everyone to understand their impact on an entire operation. Ultimately, companies find their staff adopting an increasingly broad enterprise perspective rather than a departmental one” (McKeen and Smith 2003, p. 143). This paper challenges this conventional wisdom that equates technical integration and socio-cognitive integration. The “impacts” of ERP systems depend on organizational context and implementation process. We show that flexibility, the primary goal of ERP adoption, as well as implementation strategy factors (organizational vision, speed, and core modules) exert a positive impact on cross-functionality in small and medium enterprises but not in large firms. These findings are obtained through a study of 100 French firms, then further illustrated and built upon by investigating two medium-size firms as opposed to two large firms. The findings suggest that large firms might have fewer problems than SMEs in bringing different business functions to be integrated into the project. Further, they also might have a larger inter-organizational scope of integration, but their ERP systems do not foster cross-functionality. There is also a need for social interaction to coordinate activities effectively. In SMEs, cross-functionality may be easier to reach with adequate implementation strategy

ERP Implementation and Change: Towards a Cross Functional View

ERP (Enterprise Resource Planning) systems are characterised by particular features such as functional coverage, interdependent relationships, single database and standard management and processing rules; all of which are capable of bringing about various degrees of change within the company and, potentially, encourage a more cross-functional overview of it. However, few quantitative studies have been conducted to measure these effects. This is the background to this paper, which studied 100 French companies to arrive at the following assessment of ERP adoption. It then goes on to test the relationships between the factors influencing the ERP lifecycle ((preparation (organizational vision, process re-engineering), engineering (specific developments), implementation strategy (functional coverage and speed)), the perception of a more cross-functional overview of the company and, more globally, the scope of the change this technology brings about within the company. All these factors play significant roles, with functional coverage appearing to be a particularly important consideration, which should be addressed in future research

PGC-1α is Dispensable for Exercise-Induced Mitochondrial Biogenesis in Skeletal Muscle

Exercise confers numerous health benefits, many of which are thought to stem from exercise-induced mitochondrial biogenesis (EIMB) in skeletal muscle. The transcriptional coactivator PGC-1α, a potent regulator of metabolism in numerous tissues, is widely believed to be required for EIMB. We show here that this is not the case. Mice engineered to lack PGC-1α specifically in skeletal muscle (Myo-PGC-1αKO mice) retained intact EIMB. The exercise capacity of these mice was comparable to littermate controls. Induction of metabolic genes after 2 weeks of in-cage voluntary wheel running was intact. Electron microscopy revealed no gross abnormalities in mitochondria, and the mitochondrial biogenic response to endurance exercise was as robust in Myo-PGC-1αKO mice as in wildtype mice. The induction of enzymatic activity of the electron transport chain by exercise was likewise unperturbed in Myo-PGC-1αKO mice. These data demonstrate that PGC-1α is dispensable for exercise-induced mitochondrial biogenesis in skeletal muscle, in sharp contrast to the prevalent assumption in the field

Development of dilated cardiomyopathy and impaired calcium homeostasis with cardiac-specific deletion of ESRRβ.

Mechanisms underlying the development of idiopathic dilated cardiomyopathy (DCM) remain poorly understood. Using transcription factor expression profiling, we identified estrogen-related receptor-β (ESRRβ), a member of the nuclear receptor family of transcription factors, as highly expressed in murine hearts and other highly oxidative striated muscle beds. Mice bearing cardiac-specific deletion of ESRRβ (MHC-ERRB KO) develop DCM and sudden death at ~10 mo of age. Isolated adult cardiomyocytes from the MHC-ERRB KO mice showed an increase in calcium sensitivity and impaired cardiomyocyte contractility, which preceded echocardiographic cardiac remodeling and dysfunction by several months. Histological analyses of myocardial biopsies from patients with various cardiomyopathies revealed that ESRRβ protein is absent from the nucleus of cardiomyocytes from patients with DCM but not other forms of cardiomyopathy (ischemic, hypertrophic, and arrhythmogenic right ventricular cardiomyopathy). Taken together these observations suggest that ESRRβ is a critical component in the onset of DCM by affecting contractility and calcium balance.NEW & NOTEWORTHY Estrogen-related receptor-β (ESRRβ) is highly expressed in the heart and cardiac-specific deletion results in the development of a dilated cardiomyopathy (DCM). ESRRβ is mislocalized in human myocardium samples with DCM, suggesting a possible role for ESRRβ in the pathogenesis of DCM in humans

ADAM10 is essential for Notch2-dependent marginal zone B cell development and CD23 cleavage in vivo

The proteolytic activity of a disintegrin and metalloproteinase 10 (ADAM10) regulates cell-fate decisions in Drosophila and mouse embryos. However, in utero lethality of ADAM10−/− mice has prevented examination of ADAM10 cleavage events in lymphocytes. To investigate their role in B cell development, we generated B cell–specific ADAM10 knockout mice. Intriguingly, deletion of ADAM10 prevented development of the entire marginal zone B cell (MZB) lineage. Additionally, cleavage of the low affinity IgE receptor, CD23, was profoundly impaired, but subsequent experiments demonstrated that ADAM10 regulates CD23 cleavage and MZB development by independent mechanisms. Development of MZBs is dependent on Notch2 signaling, which requires proteolysis of the Notch2 receptor by a previously unidentified proteinase. Further experiments revealed that Notch2 signaling is severely impaired in ADAM10-null B cells. Thus, ADAM10 critically regulates MZB development by initiating Notch2 signaling. This study identifies ADAM10 as the in vivo CD23 sheddase and an important regulator of B cell development. Moreover, it has important implications for the treatment of numerous CD23- and Notch-mediated pathologies, ranging from allergy to cancer

Ground Calcium Carbonate as a Low Cost and Biosafety Excipient for Solubility and Dissolution Improvement of Praziquantel

Calcium carbonate is an abundant mineral with several advantages to be a successful carrier to improve oral bioavailability of poorly water-soluble drugs, such as praziquantel. Praziquantel is an antiparasitic drug classified in group II of the Biopharmaceutical Classification System hence characterized by high-permeability and low-solubility. Therefore, the dissolution rate is the limiting factor for the gastrointestinal absorption that contributes to the low bioavailability. Consequently, the therapeutic dose of the praziquantel must be high and big tablets and capsules are required, which are difficult to swallow, especially for pediatric and elderly patients. Mixtures of praziquantel and calcium carbonate using solid-solid physical mixtures and solid dispersions were prepared and characterized using several techniques (X-ray diffraction differential scanning calorimetry, thermogravimetric analysis, scanning electron microscopy, laser diffraction, Fourier transform infrared and Raman spectroscopies). Solubility of these formulations evidenced that the solubility of praziquantel-calcium carbonate interaction product increased in physiological media. In vitro dissolution tests showed that the interaction product increased the dissolution rate of the drug in acidic medium. Theoretical models were studied to understand this experimental behavior. Cytotoxicity and cell cycle studies were performed, showing that praziquantel-calcium carbonate physical mixture and interaction product were biocompatible with the HTC116 cells, because it did not produce a decrease in cell viability or alterations in the cell cycle.We also acknowledge for financial support the MINECO, for projects FIS2016-77692-C2-2-P and CGL2016-80833-R, and the Andalusian government, for project RNM1897

Implementation Research Is Needed to Achieve International Health Goals

Sanders and Haines discuss the "knowledge-implementation gap" and identify key obstacles to correcting the gap